Core Points - The controlling shareholder of Mingchen Health, Chen Qinfang, holds 93.34 million shares, accounting for 35.02% of the total shares, and plans to reduce his holdings by up to 7.9 million shares, representing 3% of the total shares, between December 2, 2025, and March 1, 2026 [1] - The planned reduction includes a maximum of 2.6 million shares through centralized bidding and 5.3 million shares through block trading [1] - Additionally, board executives Peng Xiaoqing and Chen Dongsong intend to reduce their holdings by up to 390,000 shares and 320,000 shares, respectively, which represent 0.15% and 0.12% of the total shares, with current holdings of 0.59% and 0.48% [1]

Core Points - The company Mingchen Health announced a share reduction plan by its controlling shareholder and executives [1] - The controlling shareholder Chen Qinfang plans to reduce his holdings by up to 7,900,000 shares, representing 3% of the total share capital [1] - Executives Peng Xiaoqing and Chen Dongsong also plan to reduce their holdings by 390,000 shares (0.15%) and 320,000 shares (0.12%) respectively [1] Summary by Category - **Shareholder Actions** - Controlling shareholder Chen Qinfang holds 93,338,604 shares, which is 35.02% of the total share capital, and plans to reduce his holdings [1] - Executive Peng Xiaoqing holds 1,568,820 shares (0.59%) and plans to reduce by 390,000 shares [1] - Executive Chen Dongsong holds 1,281,708 shares (0.48%) and plans to reduce by 320,000 shares [1] - **Reduction Timeline** - The reduction will occur within three months starting from December 2, 2025, to March 1, 2026, after a 15 trading day notice period [1]

Core Viewpoint - The major shareholders of Zhicheng Health (002919.SZ) plan to reduce their holdings in the company through various trading methods within a specified timeframe [1] Shareholder Reduction Plans - The controlling shareholder and actual controller, Chen Qinfang, intends to reduce his holdings by up to 7.9 million shares, which represents no more than 3% of the company's total share capital, during the period from December 2, 2025, to March 1, 2026 [1] - Director and executive Peng Xiaoqing plans to reduce his holdings by up to 390,000 shares, accounting for no more than 0.15% of the company's total share capital, within the same timeframe [1] - Director and executive Chen Dongsong aims to reduce his holdings by up to 320,000 shares, which is no more than 0.12% of the company's total share capital, during the specified period [1]

Core Viewpoint - The company Mingchen Health (002919.SZ) announced a share reduction plan by its major shareholders and executives, indicating potential changes in ownership structure and investor sentiment [1] Share Reduction Plans - The controlling shareholder and actual controller, Chen Qinfang, plans to reduce his holdings by up to 7.9 million shares, which is no more than 3% of the company's total share capital, within three months starting from December 2, 2025, to March 1, 2026 [1] - Executive director and senior management member, Peng Xiaoqing, intends to reduce his holdings by up to 390,000 shares, representing no more than 0.15% of the company's total share capital, during the same period [1] - Another executive director, Chen Dongsong, plans to reduce his holdings by up to 320,000 shares, accounting for no more than 0.12% of the company's total share capital, also within the specified three-month timeframe [1]

Summary of Key Points Core Viewpoint - On November 10, several A-share listed companies disclosed their shareholding changes, with some announcing share buybacks while others reported share reductions by major shareholders [1]. Group 1: Share Buybacks - Hangcai Co. proposed to use 50 million to 100 million yuan of surplus funds for share repurchase [2]. - Sunong Bank executives plan to increase their holdings by no less than 1.8 million yuan in A-shares within six months [2]. - Jiangsu Cable's controlling shareholder received loan support for increasing A-share holdings [2]. Group 2: Share Reductions - A total of 25 A-share listed companies announced share reductions, including: - Aojing Medical plans to reduce no more than 0.19% of its shares by directors and executives [2]. - Maipu Medical's shareholder Guoshou Chengda intends to reduce no more than 1% of its shares [2]. - Shoulv Hotel's Ctrip Shanghai reduced 25.206 million shares on November 10 [2]. - Mingchen Health's controlling shareholder plans to reduce no more than 3% of the total share capital [2]. - Meiri Interactive's shareholder "I Got a Push" intends to reduce no more than 1% of its shares [2]. - Qicai Chemical's shareholder Beijing Fengyan plans to reduce no more than 0.98% of its shares [2]. - Other companies with planned reductions include Zhongheng Design, Xin Kaipu, Lianying Laser, Hongxin Electronics, and others, with reductions ranging from 0.07% to 5% [2].

董事、高管陈东松持有本公司股份1,281,708股，占公司总股本比例0.48%,计划在本减持计划公告之日起 15个交易日后的3个月内（即2025年12月2日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持 本公司股份不超过320,000股（不超过公司总股本的0.12%）。 董事、高管彭小青持有本公司股份1,568,820股，占公司总股本比例0.59%,计划在本减持计划公告之日起 15个交易日后的3个月内（即2025年12月2日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持 本公司股份不超过390,000股（不超过公司总股本的0.15%）。 格隆汇11月10日丨名臣健康(002919.SZ)公布，控股股东、实际控制人陈勤发持有本公司股份93,338,604 股，占公司总股本比例35.02%,计划在本减持计划公告之日起15个交易日后的3个月内（即2025年12月2 日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持本公司股份不超过7,900,000股（不超过公 司总股本的3%）。 ...

每经AI快讯，11月10日，名臣健康（002919）(002919.SZ)公告称，公司控股股东、实际控制人陈勤发 计划减持不超过790万股，占公司总股本的3%。董事、高管彭小青计划减持不超过39万股，占公司总股 本的0.15%。董事、高管陈东松计划减持不超过32万股，占公司总股本的0.12%。减持期间为自公告披 露之日起15个交易日后的3个月内。减持原因为个人资金需求。 ...

Core Viewpoint - The company Mingchen Health (002919) announced plans for significant share reductions by its major shareholders, indicating potential changes in ownership dynamics and investor sentiment [1] Shareholder Reductions - The controlling shareholder and actual controller, Chen Qinfang, intends to reduce his holdings by up to 7.9 million shares, which represents no more than 3% of the company's total share capital [1] - Company director and senior executive Peng Xiaoqing plans to reduce his holdings by up to 390,000 shares, accounting for no more than 0.15% of the total share capital [1] - Company director and senior executive Chen Dongsong aims to reduce his holdings by up to 320,000 shares, representing no more than 0.12% of the total share capital [1]

每经头条（nbdtoutiao）——进博会"爆品"来袭！德国"天价"扳手引围观，阿根廷牛儿为中国"贴膘"，卢 旺达咖啡豆火出圈…… 2025年1至6月份，名臣健康的营业收入构成为：软件和信息技术服务业占比76.84%，化学原料和化学 制品制造业占比23.16%。 （记者 曾健辉） 每经AI快讯，名臣健康（SZ 002919，收盘价：19.5元）11月10日晚间发布公告称，控股股东、实际控 制人陈勤发持有公司股份约9334万股，占公司总股本比例为35.02%，计划在本减持计划公告之日起15 个交易日后的3个月内以集中竞价交易或大宗交易方式合计减持公司股份不超过790万股。董事、高管彭 小青持有公司股份约157万股，占公司总股本比例为0.59%计划在本减持计划公告之日起15个交易日后 的3个月内以集中竞价交易或大宗交易方式合计减持公司股份不超过39万股。董事、高管陈东松持有公 司股份约128万股，占公司总股本比例为0.48%计划在本减持计划公告之日起15个交易日后的3个月内以 集中竞价交易或大宗交易方式合计减持公司股份不超过32万股。 截至发稿，名臣健康市值为52亿元。 ...

董事、高管彭小青持有本公司股份1,568,820股，占公司总股本比例0.59%,计划在本减持计划公告之日起 15个交易日后的3个月内（即2025年12月2日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持 本公司股份不超过390,000股（不超过公司总股本的0.15%）。 格隆汇11月10日丨名臣健康(002919.SZ)公布，控股股东、实际控制人陈勤发持有本公司股份93,338,604 股，占公司总股本比例35.02%,计划在本减持计划公告之日起15个交易日后的3个月内（即2025年12月2 日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持本公司股份不超过7,900,000股（不超过公 司总股本的3%）。 董事、高管陈东松持有本公司股份1,281,708股，占公司总股本比例0.48%,计划在本减持计划公告之日起 15个交易日后的3个月内（即2025年12月2日至2026年3月1日）以集中竞价交易或大宗交易方式合计减持 本公司股份不超过320,000股（不超过公司总股本的0.12%）。 ...